Home Glaukos Corporation

Glaukos Corporation

Glaukos Completes Acquisition of Avedro, Inc

As a result of the acquisition’s close, Avedro’s common stock will now cease to trade on the Nasdaq.

American Society of Cataract and Refractive Surgery to Include Multiple Glaukos Technologies Presentations

4/11/18: Clinical trial results and personal experience data will be discussed to be discussed.

International Study Shows Two Glaukos iStent® Trabecular Micro-Bypass Stents and One Topical Medication Deliver Sustained IOP Reduction

  86% of Eyes Had IOP ≤ 18 mm Hg at Three Years Postoperative, According to Results Published...

Glaukos Corporation Acquires IOP Sensor System from DOSE Medical

Early-Stage Sensor Technology Expected to Complement the Glaukos Pipeline of Micro-Scale Glaucoma Devices and Drug-Delivery Systems April 12,...